.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Citi
Dow
Cantor Fitzgerald
Boehringer Ingelheim
Fish and Richardson
Chinese Patent Office
US Army
Fuji
Cipla

Generated: December 14, 2017

DrugPatentWatch Database Preview

Suppliers and packages for NDA: 040368

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Impax PharmsORPHENADRINE CITRATEorphenadrine citrateTABLET, EXTENDED RELEASE;ORAL040368ANDAImpax Generics0115-2011-01100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-2011-01)
Impax PharmsORPHENADRINE CITRATEorphenadrine citrateTABLET, EXTENDED RELEASE;ORAL040368ANDAImpax Generics0115-2011-02500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-2011-02)
Impax PharmsORPHENADRINE CITRATEorphenadrine citrateTABLET, EXTENDED RELEASE;ORAL040368ANDASTAT RX USA LLC16590-177-2020 TABLET, EXTENDED RELEASE in 1 BOTTLE (16590-177-20)
Impax PharmsORPHENADRINE CITRATEorphenadrine citrateTABLET, EXTENDED RELEASE;ORAL040368ANDASTAT RX USA LLC16590-177-9090 TABLET, EXTENDED RELEASE in 1 BOTTLE (16590-177-90)
Impax PharmsORPHENADRINE CITRATEorphenadrine citrateTABLET, EXTENDED RELEASE;ORAL040368ANDASTAT RX USA LLC16590-177-6060 TABLET, EXTENDED RELEASE in 1 BOTTLE (16590-177-60)
Impax PharmsORPHENADRINE CITRATEorphenadrine citrateTABLET, EXTENDED RELEASE;ORAL040368ANDASTAT RX USA LLC16590-177-066 TABLET, EXTENDED RELEASE in 1 BOTTLE (16590-177-06)
Impax PharmsORPHENADRINE CITRATEorphenadrine citrateTABLET, EXTENDED RELEASE;ORAL040368ANDASTAT RX USA LLC16590-177-71100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16590-177-71)
Impax PharmsORPHENADRINE CITRATEorphenadrine citrateTABLET, EXTENDED RELEASE;ORAL040368ANDASTAT RX USA LLC16590-177-72120 TABLET, EXTENDED RELEASE in 1 BOTTLE (16590-177-72)
Impax PharmsORPHENADRINE CITRATEorphenadrine citrateTABLET, EXTENDED RELEASE;ORAL040368ANDASTAT RX USA LLC16590-177-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (16590-177-30)
Impax PharmsORPHENADRINE CITRATEorphenadrine citrateTABLET, EXTENDED RELEASE;ORAL040368ANDASTAT RX USA LLC16590-177-1515 TABLET, EXTENDED RELEASE in 1 BOTTLE (16590-177-15)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Fish and Richardson
Accenture
Cerilliant
Merck
Chinese Patent Office
Mallinckrodt
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot